Adler Eric's most recent trade in Lexeo Therapeutics Inc. was a trade of 615 Common Stock done at an average price of $9.3 . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.27 per share. | 18 Nov 2025 | 615 | 72,646 | - | 9.3 | 5,701 | Common Stock |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 9,570 | 76,643 | - | 0 | Common Stock | |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 15 Oct 2025 | 3,344 | 73,299 | - | 8.9 | 29,879 | Common Stock |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.55 per share. | 15 Oct 2025 | 38 | 73,261 | - | 9.6 | 363 | Common Stock |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 18 Aug 2025 | 608 | 67,073 | - | 4.7 | 2,838 | Common Stock |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 16 May 2025 | 585 | 67,681 | - | 2.8 | 1,623 | Common Stock |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 19 Feb 2025 | 2,359 | 68,266 | - | 4.4 | 10,410 | Common Stock |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 87,500 | 87,500 | - | - | Stock Option (right to buy) | |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 43,750 | 70,625 | - | 0 | Common Stock | |
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 161,250 | 161,250 | - | - | Employee Stock Option (right to buy) | |
| Lexeo Therapeutics Inc | Adler Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 26,875 | 26,875 | - | 0 | Common Stock |